Biomedical Engineering Reference
In-Depth Information
56. Mitchell JP, Dolovich MB (2012) Clinically relevant test methods to establish in vitro
equivalence for spacers and valved holding chambers used with pressurized metered dose
inhalers (MDIs). J Aerosol Med Pulm Drug Deliv 25(4):217-242
57. Dolovich MB (2004) In my opinion: interview with the expert. Pediatr Asthma Allergy
Immunol 17(4):292-300
58. Morton RW, Mitchell JP (2007) Design of facemasks for delivery of aerosol-based medication
via pressurized metered dose inhaler with valved holding chamber: Key issues that affect
performance. J Aerosol Med 20(S1):S29-S45
59. Finlay WH, Zuberbuhler P (1999) In vitro comparison of salbutamol hydrofl uoroalkane
(Airomir) metered dose inhaler aerosols inhaled during pediatric tidal breathing from fi ve
valved holding chambers. J Aerosol Med 12(4):285-291
60. Shah SA, Berlinski A, Rubin BK (2006) Force-dependent static dead space of face masks used
with holding chambers. Respir Care 51(2):140-144
61. Mitchell JP, Finlay JB, Nuttall JM, Limbrick MR, Nagel MW, Avvakoumova V, MacKay H,
Ali RS, Doyle CC (2011) Validation of a new model infant face with nasopharynx for the test-
ing of valved holding chambers (VHCs) with facemask as a patient interface. In: Dalby RN,
Byron PR, Peart J, Suman JD, Farr SJ (eds) Respiratory drug delivery-2010. Davis Healthcare
International Publishing LLC, River Grove, IL, pp 777-780
62. Mitchell JP (2008) Appropriate face models for evaluating drug delivery in the laboratory: the
current situation and prospects for future advances. J Aerosol Med 21(1):1-15
63. Storey-Bischoff J, Noga M, Finlay WH (2008) Deposition of micrometer-sized aerosol parti-
cles in infant nasal airway replicas. J Aerosol Sci 39(12):1055-1065
64. Newhouse MT (1998) The current laboratory determination of “Respirable Mass” is not clini-
cally relevant. J Aerosol Med 11(S1):S122-S132
65. Labiris NR, Dolovich MB (2003) Pulmonary drug delivery. Part I: physiological factors affect-
ing therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 5(12):588-599
66. Marple VA, Olson BA, Santhanakrishnan K, Mitchell JP, Murray SC, Hudson-Curtis BL
(2004) Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler
testing. Part III. Extension of archival calibration to 15 L/min. J Aerosol Med 17(4):335-343
Search WWH ::
Custom Search